A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of KUR-101 in Healthy Adults

NCT05114265 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Pain

Interventions

DRUG: KUR-101
DRUG: OxyNorm
DRUG: Placebo

Sponsor

Kures, Inc.